Resources for Food and Drug Administration (FDA)

FDA approves anti-nausea patch for chemo patients

ap.google.com

Cancer patients will soon be able to use a medication patch to ease the debilitating nausea that often accompanies chemotherapy.

The Food and Drug Administration said Monday it has approved the first anti-nausea patch for chemotherapy patients, intended to provide relief for up to five days. The patch, called Sancuso, is worn on the arm and delivers a widely used anti-nausea medicine, known as granisetron, through the skin. It is expected to be available by the end of the year.

"It will be another way that we can address nausea and vomiting, coming from a route that we haven't had before," said nurse practitioner Barbara Rogers, who specializes in cancer treatment. "The patch is a nice option."

View the Resource

Share or bookmarklet this web page at: